APOB and depressive symptom measurement: Our results revealed that higher levels of the ApoB and gTyG indices were significantly associated with an increased risk of depression, with odds ratios for ApoB Q2, Q3, and Q4 being 1.53, 3.00, and 7.90 times higher than those of the Q1 group, respectively (P < 0.001).